PhotoBarr

RSS
Withdrawn

This medicine's authorisation has been withdrawn

porfimer sodium
MedicineHumanWithdrawn
  • Application under evaluation
  • CHMP opinion
  • European Commission decision

Overview

The marketing authorisation for Photobarr has been withdrawn at the request of the marketing authorisation holder.

български (BG) (446.07 KB - PDF)

View

español (ES) (349.12 KB - PDF)

View

čeština (CS) (409.41 KB - PDF)

View

dansk (DA) (349.11 KB - PDF)

View

Deutsch (DE) (351.05 KB - PDF)

View

eesti keel (ET) (362.9 KB - PDF)

View

ελληνικά (EL) (778.07 KB - PDF)

View

français (FR) (350.61 KB - PDF)

View

italiano (IT) (349.64 KB - PDF)

View

latviešu valoda (LV) (416.02 KB - PDF)

View

lietuvių kalba (LT) (378.39 KB - PDF)

View

magyar (HU) (400.91 KB - PDF)

View

Malti (MT) (440.36 KB - PDF)

View

Nederlands (NL) (346.54 KB - PDF)

View

polski (PL) (409.39 KB - PDF)

View

português (PT) (347.66 KB - PDF)

View

română (RO) (379.9 KB - PDF)

View

slovenčina (SK) (405.55 KB - PDF)

View

slovenščina (SL) (401.33 KB - PDF)

View

Suomi (FI) (348.91 KB - PDF)

View

svenska (SV) (362.29 KB - PDF)

View

Product information

български (BG) (1.51 MB - PDF)

View

español (ES) (761.23 KB - PDF)

View

čeština (CS) (1.32 MB - PDF)

View

dansk (DA) (665.92 KB - PDF)

View

Deutsch (DE) (818.55 KB - PDF)

View

eesti keel (ET) (679.01 KB - PDF)

View

ελληνικά (EL) (3.45 MB - PDF)

View

français (FR) (743.86 KB - PDF)

View

íslenska (IS) (1.12 MB - PDF)

View

italiano (IT) (725.89 KB - PDF)

View

latviešu valoda (LV) (1.49 MB - PDF)

View

lietuvių kalba (LT) (847.91 KB - PDF)

View

magyar (HU) (1.32 MB - PDF)

View

Malti (MT) (1.39 MB - PDF)

View

Nederlands (NL) (722.02 KB - PDF)

View

norsk (NO) (1.1 MB - PDF)

View

polski (PL) (1.46 MB - PDF)

View

português (PT) (745.16 KB - PDF)

View

română (RO) (929.66 KB - PDF)

View

slovenčina (SK) (1.25 MB - PDF)

View

slovenščina (SL) (1.2 MB - PDF)

View

Suomi (FI) (675.92 KB - PDF)

View

svenska (SV) (667.04 KB - PDF)

View
Latest procedure affecting product information: T/0027
20/04/2012
icon globe

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

español (ES) (227.88 KB - PDF)

View

čeština (CS) (300.5 KB - PDF)

View

dansk (DA) (227.86 KB - PDF)

View

Deutsch (DE) (227.91 KB - PDF)

View

eesti keel (ET) (269.44 KB - PDF)

View

ελληνικά (EL) (301.42 KB - PDF)

View

français (FR) (227.85 KB - PDF)

View

italiano (IT) (227.42 KB - PDF)

View

latviešu valoda (LV) (302.67 KB - PDF)

View

lietuvių kalba (LT) (291.78 KB - PDF)

View

magyar (HU) (290.79 KB - PDF)

View

Nederlands (NL) (228.12 KB - PDF)

View

polski (PL) (304.7 KB - PDF)

View

português (PT) (227.92 KB - PDF)

View

slovenčina (SK) (301.35 KB - PDF)

View

slovenščina (SL) (290.42 KB - PDF)

View

Suomi (FI) (228.16 KB - PDF)

View

svenska (SV) (227.88 KB - PDF)

View

български (BG) (401.8 KB - PDF)

View

español (ES) (257.08 KB - PDF)

View

čeština (CS) (383.62 KB - PDF)

View

dansk (DA) (257.99 KB - PDF)

View

Deutsch (DE) (257.86 KB - PDF)

View

eesti keel (ET) (257.3 KB - PDF)

View

ελληνικά (EL) (698.87 KB - PDF)

View

français (FR) (258.49 KB - PDF)

View

italiano (IT) (257.53 KB - PDF)

View

latviešu valoda (LV) (391.62 KB - PDF)

View

lietuvių kalba (LT) (335.14 KB - PDF)

View

magyar (HU) (355.07 KB - PDF)

View

Malti (MT) (426.52 KB - PDF)

View

Nederlands (NL) (258.49 KB - PDF)

View

polski (PL) (367.46 KB - PDF)

View

português (PT) (259.14 KB - PDF)

View

română (RO) (334.53 KB - PDF)

View

slovenčina (SK) (446.1 KB - PDF)

View

slovenščina (SL) (371.02 KB - PDF)

View

Suomi (FI) (256.03 KB - PDF)

View

svenska (SV) (257.5 KB - PDF)

View

Product details

Name of medicine
PhotoBarr
Active substance
porfimer sodium
International non-proprietary name (INN) or common name
porfimer sodium
Therapeutic area (MeSH)
Barrett Esophagus
Anatomical therapeutic chemical (ATC) code
L01XD01

Pharmacotherapeutic group

Antineoplastic agents

Therapeutic indication

Photodynamic therapy (PDT) with PhotoBarr is indicated for:

  • Ablation of high-grade dysplasia (HGD) in patients with Barrett's Oesophagus (BO)

Authorisation details

EMA product number
EMEA/H/C/000493
Marketing authorisation holder
Pinnacle Biologics B.V. 

Pinnacle Biologics B.V.
p/a Trust Company Amsterdam B.V.
Crystal Tower 21st Floor
Orlyplein 10
1043 DP Amsterdam
The Netherlands

Marketing authorisation issued
25/03/2004
Revision
9

Assessment history

This page was last updated on

Share this page